Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-10-29

Clinical Trial Update: Safety, Efficacy Assessment of Geltim LP® 1 mg/g in Ocular Hypertensive or Glaucomatous Patients. [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the safety and efficacy of Geltim LP 1 mg/g in ocular hypertensive or glaucomatous patients. Results have been posted after trial compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Geltim LP

Snippet

Sponsor: Laboratoires Thea | Conditions: Glaucoma | Phase 4 | Status: COMPLETED | Results posted: 2014-10-29